Tag: prefibrotic primary myelofibrosis

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

byKathleen Lau

January 29, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Poor baseline lung function associated with increased risk of incident tuberculosis
Endothelial Activation and Stress Index as a predictor of mortality in patients with atrial fibrillation
No difference between pharmacologic treatments in age-related macular degeneration risk reduction

No Result

View All Result